Malcolm K Brenner, MD
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Malcolm K Brenner, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:19 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00710892 · CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide GeneBaylor College of Medicine · active not recruiting · Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome · principal investigator
- Ph1NCT00383097 · Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's LymphomaBaylor College of Medicine · terminated · Hodgkins Lymphoma, Non-Hodgkin Lymphoma · study director
- Ph1NCT00224354 · Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor CellsBaylor College of Medicine · withdrawn · CHRONIC LYMPHOCYTIC B-LEUKEMIA · study director
- Ph1NCT00078520 · Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor CellsBaylor College of Medicine · completed · Leukemia, Leukemia, B-Cell, Chronic · study chair
- Ph1NCT00058786 · Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor CellsBaylor College of Medicine · completed · Chronic Lymphocytic B-Leukemia · principal investigator
- Ph1NCT00058799 · Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor VaccineBaylor College of Medicine · completed · Leukemia · principal investigator
- Ph1NCT00057005 · Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell TransplantationBaylor College of Medicine · completed · LEUKEMIA · study chair
- Ph1/Ph2NCT00056966 · Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesBaylor College of Medicine · completed · Hematologic Malignancy · study chair
- Ph1/Ph2NCT00056979 · Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage DiseasesBaylor College of Medicine · terminated · Inherited Metabolic Storage Diseases · study chair
- Ph2NCT00040469 · Bone Marrow Transplant From Related Donor for Patients With High Risk HemoglobinopathiesBaylor College of Medicine · terminated · Sickle Cell Anemia, Hemoglobinopathy, Thalassemia · study chair
- Ph2NCT00040482 · High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisBaylor College of Medicine · completed · Multiple Sclerosis · study chair
- Ph2NCT00040417 · Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk HemoglobinopathiesBaylor College of Medicine · terminated · Sickle Cell Anemia, Hemoglobinopathy, Thalassemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.